Characterization of lead in US workplaces using data from OSHA's integrated management information system
Scott A Henn1, Aaron L Sussell, Jia Li
1Division of Surveillance, Hazard Evaluations, and Field Studies (DSHEFS), National Institute for Occupational Safety and Health (NIOSH), Cincinnati, Ohio 45226, USA. SHenn@cdc.gov
Workplace lead hazards are most prevalent in the construction industry and in the northern and northeastern US. Data from the Occupational Safety and Health Administration
Area of Science:
- Occupational Health
- Environmental Health
- Industrial Hygiene
Background:
- Workplace lead exposure remains a significant occupational hazard.
- The Occupational Safety and Health Administration's Integrated Management Information System (IMIS) database is a key resource for US workplace sampling results.
Purpose of the Study:
- To analyze lead sampling data from the IMIS database to identify high-risk sectors and geographical areas.
- To understand factors associated with exceeding the Permissible Exposure Limit (PEL) for lead.
Main Methods:
- Extracted personal airborne lead sampling results from IMIS (1979-2008).
- Conducted descriptive analyses, geographical mapping, and regression modeling.
- Identified factors associated with lead sample results exceeding the PEL.
Main Results:
- Manufacturing accounted for 79% of lead samples.
- Construction sector showed the highest lead concentrations (median 0.03 mg/m³).
- Several factors, including NORA sector, year, OSHA region, and worksite characteristics, were linked to PEL exceedances.
Conclusions:
- Construction industry exhibits higher lead concentrations compared to other sectors.
- Lead hazards are most common in the northern and northeastern United States.
- IMIS data serves as a valuable tool for surveillance and targeted prevention of lead hazards.
Related Concept Videos
Hazard Analysis and Critical Control Points (HACCP)
Mechanistic Models: Compartment Models in Individual and Population Analysis
PPE Use in Healthcare Settings I: Donning
PPE Use in Healthcare Settings II: Doffing
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview
Analysis of Population Pharmacokinetic Data

